A Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP of the European Pharmacopoeia monograph is often referred to as a Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g Certificate of Suitability (COS). The purpose of a Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g to their clients by showing that a Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP has been issued for it. The manufacturer submits a Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP (COS) as part of the market authorization procedure, and it takes on the role of a Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP holder for the record. Additionally, the data presented in the Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g DMF.
A Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Magnesium sulfate heptahydrate, ACS, 98.0-102.0% 100g suppliers with CEP (COS) on PharmaCompass.